BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 35152416)

  • 1. Influence of adjuvant nortriptyline on the efficacy of electroconvulsive therapy: A randomized controlled trial and 1-year follow-up.
    Pluijms EM; Kamperman AM; Hoogendijk WJG; van den Broek WW; Birkenhäger TK
    Acta Psychiatr Scand; 2022 May; 145(5):517-528. PubMed ID: 35152416
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Continuation pharmacotherapy in the prevention of relapse following electroconvulsive therapy: a randomized controlled trial.
    Sackeim HA; Haskett RF; Mulsant BH; Thase ME; Mann JJ; Pettinati HM; Greenberg RM; Crowe RR; Cooper TB; Prudic J
    JAMA; 2001 Mar; 285(10):1299-307. PubMed ID: 11255384
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical characteristics associated with relapse 2 years after electroconvulsive therapy for major depression.
    Pluijms EM; Vinther PT; Kamperman AM; Birkenhäger TK
    Acta Psychiatr Scand; 2023 Jun; 147(6):561-569. PubMed ID: 36938869
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Is baseline medication resistance associated with potential for relapse after successful remission of a depressive episode with ECT? Data from the Consortium for Research on Electroconvulsive Therapy (CORE).
    Rasmussen KG; Mueller M; Rummans TA; Husain MM; Petrides G; Knapp RG; Fink M; Sampson SM; Bailine SH; Kellner CH
    J Clin Psychiatry; 2009 Feb; 70(2):232-7. PubMed ID: 19192459
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Maintenance electroconvulsive therapy in elderly psychotic unipolar depression].
    Serra M; Gastó C; Navarro V; Torres X; Blanch J; Masana G
    Med Clin (Barc); 2006 Apr; 126(13):491-2. PubMed ID: 16624227
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Continuation electroconvulsive therapy vs pharmacotherapy for relapse prevention in major depression: a multisite study from the Consortium for Research in Electroconvulsive Therapy (CORE).
    Kellner CH; Knapp RG; Petrides G; Rummans TA; Husain MM; Rasmussen K; Mueller M; Bernstein HJ; O'Connor K; Smith G; Biggs M; Bailine SH; Malur C; Yim E; McClintock S; Sampson S; Fink M
    Arch Gen Psychiatry; 2006 Dec; 63(12):1337-44. PubMed ID: 17146008
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of concomitant pharmacotherapy on electroconvulsive therapy outcomes: short-term efficacy and adverse effects.
    Sackeim HA; Dillingham EM; Prudic J; Cooper T; McCall WV; Rosenquist P; Isenberg K; Garcia K; Mulsant BH; Haskett RF
    Arch Gen Psychiatry; 2009 Jul; 66(7):729-37. PubMed ID: 19581564
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Relapse during continuation pharmacotherapy after acute response to ECT: a comparison of usual care versus protocolized treatment.
    Tew JD; Mulsant BH; Haskett RF; Joan P; Begley AE; Sackeim HA
    Ann Clin Psychiatry; 2007; 19(1):1-4. PubMed ID: 17453654
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacological strategies in the prevention of relapse after electroconvulsive therapy.
    Prudic J; Haskett RF; McCall WV; Isenberg K; Cooper T; Rosenquist PB; Mulsant BH; Sackeim HA
    J ECT; 2013 Mar; 29(1):3-12. PubMed ID: 23303417
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Relapse Prevention in Major Depressive Disorder After Successful Acute Electroconvulsive Treatment: a 6-month Double-blind Comparison of Three Fixed Dosages of Escitalopram and a Fixed Dose of Nortriptyline - Lessons from a Failed Randomised Trial of the Danish University Antidepressant Group (DUAG-7).
    Martiny K; Larsen ER; Licht RW; Nielsen CT; Damkier P; Refsgaard E; Lunde M; Straasø B; Christensen EM; Lolk A; Holmskov J; Sørensen CH; Brødsgaard I; Eftekhari SZ; Bendsen BB; Klysner R; Terp IM; Larsen JK; Vestergaard P; Buchholtz PE; Gram LF; Bech P;
    Pharmacopsychiatry; 2015 Nov; 48(7):274-8. PubMed ID: 26529118
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Continuation/maintenance treatment with nortriptyline versus combined nortriptyline and ECT in late-life psychotic depression: a two-year randomized study.
    Navarro V; Gastó C; Torres X; Masana G; Penadés R; Guarch J; Vázquez M; Serra M; Pujol N; Pintor L; Catalán R
    Am J Geriatr Psychiatry; 2008 Jun; 16(6):498-505. PubMed ID: 18515694
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Health-related quality of life in a clinical trial of ECT followed by continuation pharmacotherapy: effects immediately after ECT and at 24 weeks.
    McCall WV; Rosenquist PB; Kimball J; Haskett R; Isenberg K; Prudic J; Lasater B; Sackeim HA
    J ECT; 2011 Jun; 27(2):97-102. PubMed ID: 21206285
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of the efficacy of electroconvulsive therapy (ECT) plus agomelatine to ECT plus placebo in treatment-resistant depression.
    Lin CH; Yang WC; Chen CC; Cai WR
    Acta Psychiatr Scand; 2020 Aug; 142(2):121-131. PubMed ID: 32412097
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Speed of remission in elderly patients with depression: electroconvulsive therapy v. medication.
    Spaans HP; Sienaert P; Bouckaert F; van den Berg JF; Verwijk E; Kho KH; Stek ML; Kok RM
    Br J Psychiatry; 2015 Jan; 206(1):67-71. PubMed ID: 25323140
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effectiveness of Emotional Memory Reactivation vs Control Memory Reactivation Before Electroconvulsive Therapy in Adult Patients With Depressive Disorder: A Randomized Clinical Trial.
    Scheepens DS; van Waarde JA; Ten Doesschate F; Westra M; Kroes MCW; Schene AH; Bockting CLH; Schoevers RA; Denys DAJP; Ruhé HG; van Wingen GA
    JAMA Netw Open; 2020 Aug; 3(8):e2012389. PubMed ID: 32749468
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Vascular risk factors in older patients with depression: outcome of electroconvulsive therapy versus medication.
    Spaans HP; Kok RM; Bouckaert F; Van Den Berg JF; Tunney OC; Sienaert P; Verwijk E; Kho KH; Stek ML
    Int J Geriatr Psychiatry; 2018 Feb; 33(2):371-378. PubMed ID: 28657697
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Imipramine is effective in preventing relapse in electroconvulsive therapy-responsive depressed inpatients with prior pharmacotherapy treatment failure: a randomized, placebo-controlled trial.
    van den Broek WW; Birkenhäger TK; Mulder PG; Bruijn JA; Moleman P
    J Clin Psychiatry; 2006 Feb; 67(2):263-8. PubMed ID: 16566622
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Electroconvulsive therapy for older adult patients with major depressive disorder: a systematic review of randomized controlled trials.
    Dong M; Zhu XM; Zheng W; Li XH; Ng CH; Ungvari GS; Xiang YT
    Psychogeriatrics; 2018 Nov; 18(6):468-475. PubMed ID: 30073725
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The treatment of psychotic depression in later life: a comparison of pharmacotherapy and ECT.
    Flint AJ; Rifat SL
    Int J Geriatr Psychiatry; 1998 Jan; 13(1):23-8. PubMed ID: 9489577
    [TBL] [Abstract][Full Text] [Related]  

  • 20. ECT remission rates in psychotic versus nonpsychotic depressed patients: a report from CORE.
    Petrides G; Fink M; Husain MM; Knapp RG; Rush AJ; Mueller M; Rummans TA; O'Connor KM; Rasmussen KG; Bernstein HJ; Biggs M; Bailine SH; Kellner CH
    J ECT; 2001 Dec; 17(4):244-53. PubMed ID: 11731725
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.